Home » Teijin: Febuxostat Launches in Korea
Teijin: Febuxostat Launches in Korea
Teijin announced the launch of febuxostat, a novel drug for the treatment of hyperuricemia and gout, in Korea.
4-Traders
4-Traders
Upcoming Events
-
07May
-
14May
-
30May